These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 15761230)

  • 1. Acromegaly and serum insulin-like growth factor I.
    Thorner MO
    Horm Res; 2004; 62 Suppl 1():34-6. PubMed ID: 15761230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum IGF-I measured by four different immunoassays in patients with adult GH deficiency or acromegaly and in a control population.
    Granada ML; Ulied A; Casanueva FF; Pico A; Lucas T; Torres E; Sanmartí A
    Clin Endocrinol (Oxf); 2008 Jun; 68(6):942-50. PubMed ID: 17980002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IGF-I and mortality in patients with acromegaly.
    Strasburger CJ
    J Endocrinol Invest; 2005; 28(11 Suppl International):78-80. PubMed ID: 16625852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical utility of measurements of insulin-like growth factor 1.
    Clemmons DR
    Nat Clin Pract Endocrinol Metab; 2006 Aug; 2(8):436-46. PubMed ID: 16932333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The place of insulin-like growth factor I in the diagnosis of acromegaly].
    Dohán O; Góth M; Szabolcs I; Kovács L; Kovács Z; Szilágyi G
    Orv Hetil; 1993 Oct; 134(42):2301-3. PubMed ID: 8233444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum insulin-like growth factor-I measurement in the follow-up of treated acromegaly: comparison of four immunoassays.
    Massart C; Poirier JY
    Clin Chim Acta; 2006 Nov; 373(1-2):176-9. PubMed ID: 16815351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic tests and basal values for defining active acromegaly.
    Tzanela M
    Neuroendocrinology; 2006; 83(3-4):200-4. PubMed ID: 17047383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical laboratory indices in the treatment of acromegaly.
    Clemmons DR
    Clin Chim Acta; 2011 Feb; 412(5-6):403-9. PubMed ID: 21075098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of long-term growth hormone and insulin-like growth factor-1 exposure on the development of cardiovascular, cerebrovascular and metabolic co-morbidities in treated patients with acromegaly.
    Jayasena CN; Comninos AN; Clarke H; Donaldson M; Meeran K; Dhillo WS
    Clin Endocrinol (Oxf); 2011 Aug; 75(2):220-5. PubMed ID: 21521288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical indicators of biochemical remission in acromegaly: does incomplete disease control always mean therapeutic failure?
    Damjanovic SS; Neskovic AN; Petakov MS; Popovic V; Macut D; Vukojevic P; Joksimovic MM
    Clin Endocrinol (Oxf); 2005 Apr; 62(4):410-7. PubMed ID: 15807870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pregnancy-induced changes in insulin-like growth factor I (IGF-I), insulin-like growth factor binding protein 3 (IGFBP-3), and acid-labile subunit (ALS) in patients with growth hormone (GH) deficiency and excess.
    Wiesli P; Zwimpfer C; Zapf J; Schmid C
    Acta Obstet Gynecol Scand; 2006; 85(8):900-5. PubMed ID: 16862465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [What is the value of determining immunoreactive GHRH in acromegaly?].
    Müller B; de Marco D; Bürgi U; Mullis PE
    Schweiz Med Wochenschr; 1999 Aug; 129(33):1152-61. PubMed ID: 10483668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormonal diagnosis of GH hypersecretory states.
    Grottoli S; Gasco V; Ragazzoni F; Ghigo E
    J Endocrinol Invest; 2003; 26(10 Suppl):27-35. PubMed ID: 15497657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-like growth factor binding protein-3 levels during early and late follow-up after surgery in acromegalic patients.
    Charalampaki P; Hildebrandt G; Schaeffer HJ; Schönau E; Klug N
    Exp Clin Endocrinol Diabetes; 1998; 106(2):130-4. PubMed ID: 9628244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pitfalls of insulin-like growth factor I assays.
    Bidlingmaier M
    Horm Res; 2009 Jan; 71 Suppl 1():30-3. PubMed ID: 19153502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acromegaly: the significance of serum total and free IGF-I and IGF-binding protein-3 in diagnosis.
    van der Lely AJ; de Herder WW; Janssen JA; Lamberts SW
    J Endocrinol; 1997 Oct; 155 Suppl 1():S9-13; discussion S15-6. PubMed ID: 9389990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study on the activity of acromegaly: evaluation of IGF-I].
    Larrañaga J; Carbó E; Horcajada C; Herrera Pombo JL
    Rev Clin Esp; 1991 Feb; 188(3):131-5. PubMed ID: 1780511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term monitoring of insulin-like growth factor I in adult growth hormone deficiency: a critical appraisal.
    Gibney J; Johannsson G
    Horm Res; 2004; 62 Suppl 1():66-72. PubMed ID: 15761235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of insulin-like growth factor-I in diagnosis and management of acromegaly.
    Clemmons DR
    Endocr Pract; 2004; 10(4):362-71. PubMed ID: 15760781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of acromegaly with octreotide-LAR: extensive experience in a Brazilian institution.
    Jallad RS; Musolino NR; Salgado LR; Bronstein MD
    Clin Endocrinol (Oxf); 2005 Aug; 63(2):168-75. PubMed ID: 16060910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.